Life Sciences Licensing and Collaboration Deals: Antitrust Traps for the Unwary
With an uptick in antitrust enforcement action across the US, UK, EU and China (among other jurisdictions), companies in the life...
About Me
Jenny’s practice covers contentious and non-contentious EU and UK competition law matters with experience of engaging with the European Commission, the UK Competition and Markets Authority and other competition law enforcement agencies around the world.
She has particular experience of advising clients in the financial services sector. Highlights include advising on high profile merger control transactions, including public takeovers. Based in London, she has also spent time on secondment in our Washington DC office and chairs the Freshfields associate women’s network.
Jenny is fluent in Dutch and English.
Jenny Leahy's Passles
Freshfields Technology Quotient
Insights at the intersection of technology and the law
Human Rights
Most Read
UK National Security and Investment Act: key takeaways for the life sciences industry
The UK’s National Security and Investment Act (the NSI Act), which came into force on 4 January 2022, introduced a new investment...
Life sciences – what to expect in 2022
Innovation and transformation are the watchwords for life sciences in 2022. Digitization and personalization trends are set to continue...
Life sciences – what to expect in 2022
Innovation and transformation are the watchwords for life sciences in 2022. Digitization and personalization trends are set to continue...
Getting deals through in 2022: new opportunities and risks for companies navigating a complex regulatory environment
Companies can expect tough, complex, and unpredictable merger control processes in 2022, as authorities are under pressure to tackle...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net